Works by Revuelta, José Luis


Results: 32
    1
    2

    DPYD Exome, mRNA Expression and Uracil Levels in Early Severe Toxicity to Fluoropyrimidines: An Extreme Phenotype Approach.

    Published in:
    Journal of Personalized Medicine, 2021, v. 11, n. 8, p. 792, doi. 10.3390/jpm11080792
    By:
    • Villalvazo, Priscila;
    • Marzal-Alfaro, Belén;
    • García-Alfonso, Pilar;
    • Revuelta-Herrero, José Luis;
    • Thomas, Fabienne;
    • López-Tarruella, Sara;
    • García-González, Xandra;
    • Calvo, Aitana;
    • Yakoubi, Malika;
    • Salvador-Martín, Sara;
    • López-López, Flora;
    • Aguilar, Iker;
    • Sanjurjo-Sáez, María;
    • Martín, Miguel;
    • López-Fernández, Luis Andrés
    Publication type:
    Article
    3
    4
    5
    6
    7
    8
    9
    10
    11
    12
    13
    14
    15
    16
    17
    18
    19
    20
    21
    22
    23
    24
    25

    Smartphone-Based Ecological Momentary Assessment for the Measurement of the Performance Status and Health-Related Quality of Life in Cancer Patients Under Systemic Anticancer Therapies: Development and Acceptability of a Mobile App.

    Published in:
    Frontiers in Oncology, 2022, v. 12, p. 1, doi. 10.3389/fonc.2022.880430
    By:
    • Escudero-Vilaplana, Vicente;
    • Romero-Medrano, Lorena;
    • Villanueva-Bueno, Cristina;
    • Rodríguez de Diago, Marta;
    • Yánez-Montesdeoca, Alberto;
    • Collado-Borrell, Roberto;
    • Campaña-Montes, Juan José;
    • Marzal-Alfaro, Belén;
    • Revuelta-Herrero, José Luis;
    • Calles, Antonio;
    • Galera, Mar;
    • Álvarez, Rosa;
    • Herranz, Ana;
    • Sanjurjo, María;
    • Artés-Rodríguez, Antonio
    Publication type:
    Article
    26

    Smartphone-Based Ecological Momentary Assessment for the Measurement of the Performance Status and Health-Related Quality of Life in Cancer Patients Under Systemic Anticancer Therapies: Development and Acceptability of a Mobile App.

    Published in:
    Frontiers in Oncology, 2022, v. 12, p. 1, doi. 10.3389/fonc.2022.880430
    By:
    • Escudero-Vilaplana, Vicente;
    • Romero-Medrano, Lorena;
    • Villanueva-Bueno, Cristina;
    • de Diago, Marta Rodríguez;
    • Yánez-Montesdeoca, Alberto;
    • Collado-Borrell, Roberto;
    • José Campaña-Montes, Juan;
    • Marzal-Alfaro, Belén;
    • Luis Revuelta-Herrero, José;
    • Calles, Antonio;
    • Galera, Mar;
    • Álvarez, Rosa;
    • Herranz, Ana;
    • Sanjurjo, María;
    • Artés-Rodríguez, Antonio
    Publication type:
    Article
    27
    28
    29
    30

    Complementary and alternative medicine in cancer patients: characteristics of use and interactions with antineoplastic agents.

    Published in:
    Journal of Cancer Research & Clinical Oncology, 2023, v. 149, n. 7, p. 2855, doi. 10.1007/s00432-022-04172-1
    By:
    • Escudero-Vilaplana, Vicente;
    • Collado-Borrell, Roberto;
    • Gómez Martínez-Sagrera, Patricia;
    • Villanueva-Bueno, Cristina;
    • Revuelta-Herrero, José Luis;
    • Gonzalez-Haba, Eva;
    • Hoyo-Muñoz, Ángela;
    • Jerez Gilarranz, Yolanda;
    • Marzal-Alfaro, Belén;
    • Herranz, Ana;
    • Martin, Miguel;
    • Sanjurjo, María
    Publication type:
    Article
    31
    32

    Genome-Wide Analysis of Factors Affecting Transcription Elongation and DNA Repair: A New Role for PAF and Ccr4-Not in Transcription-Coupled Repair.

    Published in:
    PLoS Genetics, 2009, v. 5, n. 2, p. 1, doi. 10.1371/journal.pgen.1000364
    By:
    • Gaillard, Hélène;
    • Tous, Cristina;
    • Botet, Javier;
    • González-Aguilera, Cristina;
    • JoséQuintero, Maria;
    • Viladevall, Laia;
    • García-Rubio, María L.;
    • Rodríguez-Gil, Alfonso;
    • Marín, Antonio;
    • Ariño, Joaquín;
    • Revuelta, José Luis;
    • Chávez, Sebastián;
    • Aguilera, Andrés
    Publication type:
    Article